StockWatch
·

Bizotic Commercial Ltd Q2 FY27 Results

BIZOTICQ2 FY27 Results
Filing
MetricValue (₹ Cr)Q2 FY26
Revenue200.83172.2%
Total Income200.83172.0%
Expenditure179.62186.8%
PBT21.2189.3%
Net Profit15.7888.3%
OPM—
NPM7.86%3.49pp
EPS2.7373.8%
View full financials
Q2 FY-2027 RESULTS · BIZOTIC

Bizotic H1 FY27: standalone PAT +88% YoY to Rs15.8 Cr, but margin dips, EPS -74% on dilution

PAT +88.31% YoY · revenue +172.17% · margins compressing

26 Oct 2026 · 3 min read
Revenue

₹200.83 Cr

+172.17% YoY

PAT (standalone)

₹15.78 Cr

+88.31% YoY

Net margin

7.86%

-3.5pp YoY

EPS

₹2.73

Bizotic Commercial's standalone H1 FY27 (half year ended 30 September 2026) revenue came in at ₹200.83 Cr, up 172% YoY from ₹73.78 Cr in H1 FY26, with net profit of ₹15.78 Cr, up 88% YoY from ₹8.38 Cr. There were no exceptional items in either period, so this is a clean YoY comparison. Basic EPS fell 74% to ₹2.73 (half-year, not annualised) from ₹10.42, purely a function of a 7.2x increase in the paid-up equity base rather than weaker fundamentals.

The scoreboard

Q2 FY-2027 vs prior quarters

Standalone P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹200.83 Cr—+172.2%
Expenses₹179.62 Cr—+186.9%
PAT₹15.78 Cr—+88.31%
Net margin7.86%—-3.5pp
EPS₹2.73—-73.8%

Profit growth lagged revenue growth by a wide margin because the cost of stock-in-trade (₹17,424.60 Lacs, ~97% of total expenses) scaled faster than revenue, pulling net profit margin down to 7.86% from 11.35% and PBT margin to 10.57% from 15.18%. Employee costs and finance costs roughly doubled to tripled YoY (₹144.33 Lacs and ₹10.53 Lacs) but remain small next to the cost-of-goods line, so the compression looks like a trading-mix/pricing effect in the core business rather than overhead creep.

₹
70.2292.59114.97137.34159.7192.207-2308-1409-0709-3010-26Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹92.2, down 18.5% over the past month of trading.

₹ Cr
05.8911.7817.670.81Q2 FY24rev ₹26 Cr2.28Q4 FY24rev ₹46 Cr1.35Q2 FY25rev ₹53 Cr2.45Q4 FY25rev ₹58 Cr8.38Q2 FY26rev ₹74 Cr15.78Q2 FY27rev ₹201 Cr
Quarterly standalone PAT, ₹ Crore

For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 3 consecutive quarters; revenue is at a 6-quarter high.

Beyond the headline

What the summary numbers don't show

No exceptional items in either period — results unaudited but reviewed under SRE 2410 with no modified opinion

Single reportable segment (Trading) under Ind-AS 108 — no dividend recommended for FY26

No brokerage previews or consensus estimates for this micro-cap (BSE scrip 543926) turned up in a web search, and the company has no formal guidance on record in our database or the filing, so both vsStreet and vsGuidance are unknown — flagged rather than guessed. Beyond the board-meeting outcome letter, no separate management press release accompanies this filing, so there is no quoted management framing to reconcile against the print. The paid-up equity base jumped from ₹804.00 Lacs to ₹5,785.20 Lacs via a preferential issue (₹5.742 Cr raised, per the funds-utilization statement, directed to working capital) — the direct cause of the EPS decline. The board separately approved a fresh share capital increase/preferential issue price on 30 September 2026, with an EGM held 23 October 2026, just ahead of this results announcement, meaning further dilution is already in motion.

  • W1

    Incremental dilution from the share capital increase/preferential issue approved 30 Sep 2026 (EGM 23 Oct 2026) — watch resulting share count and EPS impact in H2 FY27

  • W2

    NPM trajectory — compressed to 7.86% in H1 FY27 from 11.35% in H1 FY26; watch whether the trading-cost line stabilizes as revenue scales

  • W3

    H2 FY27 pacing — H1 FY27 PAT (₹15.78 Cr) is already 87% of FY26's full-year audited PAT (₹18.09 Cr); watch whether the growth rate sustains or decelerates

Informational and educational content only. Not investment advice.